Shuenn-chen Yang
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19.
Journal: Journal of nanobiotechnology
Published: October 15, 2023
PM2.5 promotes lung cancer progression through activation of the AhR-TMPRSS2-IL18 pathway.
Journal: EMBO molecular medicine
Published: October 10, 2022
Psorachromene induces apoptosis and suppresses tumor growth in NSCLC cells harboring EGFR L858R/T790M/C797S.
Journal: Phytotherapy research : PTR
Published: September 03, 2021
Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer.
Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer.
Journal: Cancer letters
Published: December 03, 2020
Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference.
Journal: Molecular therapy oncolytics
Published: May 27, 2020
4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of β-tubulin.
Journal: European journal of medicinal chemistry
Published: June 14, 2019
The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 22, 2019
Corrigendum: Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis.
Journal: Nature communications
Published: February 08, 2017
Last Updated: 09/26/2026